Boston Scientific has launched Interlock - 35 Fibered IDC Occlusion System, which helps to reduce blood flow in the peripheral vasculature during embolization procedures, in the US and Europe.
The Interlock – 35 system consists of a 0.035 detachable coil that features an interlocking connection between the coil and delivery wire which is designed to offer placement control, including the ability to advance, retract and reposition the coil before final deployment in the vessel.
The platinum coil is constructed with a dense network of synthetic fibers, designed to offer thrombogenicity (blockage of blood flow) and rapid stasis and is detached by pushing the detachment zone beyond the distal end of the 5F delivery catheter.
The IDC occlusion system is available in 31 configurations that include coil lengths from 4cm to 40cm, diameters from 3mm to 20mm, and three distinct shapes (Cube, 2D Helical and Diamond) which offers physicians flexibility to treat diverse vessel anatomy.
Boston Scientific said when combined with its 0.018′ Interlock Fibered IDC coils, the Interlock coil portfolio provides 50 different coils to optimize peripheral embolization procedures.
Boston Scientific Endovascular Unit senior vice president and president Joe Fitzgerald said the new technology offers interventional radiologists a wider range of options to address clinical and anatomic challenges in treating peripheral vascular embolizations.